Kelly Tyrrell writes about health, science and health policy. Based in Madison, Wis., she has a BS in zoology from the University of Florida and an MS in cellular and molecular biology from the University of Wisconsin–Madison. In 2011, she was a mass media dcience and engineering fellow with the American Association for the Advancement of Science (AAAS), reporting for the Chicago Tribune. Ms. Tyrrell has also worked as a health and science reporter for the News Journal (Gannett) in Wilmington, DE, a freelance reporter for the Philadelphia Inquirer and a science writer for UW-Madison.
A recent study published in Lupus Science & Medicine lays out five of the top barriers impeding progress in lupus diagnosis and treatment.1 The Addressing Lupus Pillars for Health Advancement project (ALPHA), led by the Lupus Foundation of America (LFA), researchers at the Tufts School of Medicine Center for the Study of Drug Development (Tufts… [Read More]
Daniel Solomon, MD, MPH, has practiced rheumatology for more than 20 years, all while conducting translational and clinical research and teaching young clinicians. Soon, he will also step into the role of editor in chief of Arthritis & Rheumatology, as Richard J. Bucala, MD, PhD, ends his tenure. He will assume some duties during a… [Read More]
Sindhu Johnson, MD, PhD, FRCPC, has co-chaired the classification and response criteria subcommittee and brings extensive experience in classification and guideline development to her new role.... [Read More]
Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.... [Read More]
In April 2019, the Rheumatology Association of Nevada (RAN) hosted its fourth annual meeting. “We had the largest-ever number of attendees,” says RAN President Tim Kelly, MD, a rheumatologist in Las Vegas. Launched in 2016, RAN continues to grow, and Dr. Kelly hopes to see the statewide organization do more. “We want to expand our… [Read More]
In August 2018, the Centers for Medicare and Medicaid Services (CMS) announced it would permit Medicare Advantage plans to use step therapy for Part B drugs, with a lookback period of just 108 days.1 On May 16, 2019, however, the CMS issued a final rule that extends the lookback period for Part B therapies to 365… [Read More]
A group led by Sarah Ringold, MD, MS, assistant professor of rheumatology at Seattle Children’s Hospital, has developed a new guideline intended to provide recommendations for the treatment and monitoring of children with juvenile idiopathic arthritis (JIA) manifesting as non-systemic polyarthritis, sacroiliitis or enthesitis.1,2 Key Updates The new recommendations appear in both Arthritis & Rheumatology… [Read More]
As soon as pediatric patients are diagnosed with juvenile idiopathic arthritis (JIA), they should also be screened for uveitis, says ophthalmologist Gary Holland, MD. Otherwise, the University of California, Los Angeles, provider says, “Kids who are diagnosed with JIA may not come to an ophthalmologist until they have vision-limiting complications.” Uveitis is the most common… [Read More]
Shervin Assassi, MD, MS, was the child of two physicians. His mother practiced obstetrics, and his father was a trauma surgeon. It gave him an appreciation for the hard work that goes into medicine and a fascination for joints. He developed an interest in immunology while in medical school. “It was natural for me to… [Read More]
Paul Adam, MSW, has long been passionate about research, but it was attending ACR/ARHP meetings that solidified his decision to pursue it in his social work career. “I would get Arthritis Care & Research every month and look for articles pertaining to what I did, and go to the [ACR/ARHP] Annual Meeting and see a… [Read More]